List of Excipients in API EDARAVONE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing EDARAVONE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mitsubishi Tanabe Pharma America Inc | RADICAVA | edaravone | 70510-2171 | CYSTEINE HYDROCHLORIDE | |
| Mitsubishi Tanabe Pharma America Inc | RADICAVA | edaravone | 70510-2171 | PHOSPHORIC ACID | |
| Mitsubishi Tanabe Pharma America Inc | RADICAVA | edaravone | 70510-2171 | SODIUM BISULFITE | |
| Mitsubishi Tanabe Pharma America Inc | RADICAVA | edaravone | 70510-2171 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing EDARAVONE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 | CYSTEINE HYDROCHLORIDE |
| Sandoz Inc | edaravone | 0781-3527 | PHOSPHORIC ACID |
| Sandoz Inc | edaravone | 0781-3527 | SODIUM BISULFITE |
| Sandoz Inc | edaravone | 0781-3527 | SODIUM CHLORIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for EDARAVONE
Excipient focus: CYSTEINE HYDROCHLORIDE
EDARAVONE drug variants containing CYSTEINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 |
| XGen Pharmaceuticals DJB Inc | edaravone | 39822-4500 |
| Piramal Critical Care Inc | edaravone | 66794-259 |
| Gland Pharma Limited | edaravone | 68083-500 |
| >Company | >Ingredient | >NDC |
EDARAVONE drug variants not containing CYSTEINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHOSPHORIC ACID
EDARAVONE drug variants containing PHOSPHORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 |
| XGen Pharmaceuticals DJB Inc | edaravone | 39822-4500 |
| Piramal Critical Care Inc | edaravone | 66794-259 |
| Gland Pharma Limited | edaravone | 68083-500 |
| >Company | >Ingredient | >NDC |
EDARAVONE drug variants not containing PHOSPHORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BISULFITE
EDARAVONE drug variants containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 |
| XGen Pharmaceuticals DJB Inc | edaravone | 39822-4500 |
| Piramal Critical Care Inc | edaravone | 66794-259 |
| Gland Pharma Limited | edaravone | 68083-500 |
| >Company | >Ingredient | >NDC |
EDARAVONE drug variants not containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
EDARAVONE drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 |
| XGen Pharmaceuticals DJB Inc | edaravone | 39822-4500 |
| Piramal Critical Care Inc | edaravone | 66794-259 |
| Gland Pharma Limited | edaravone | 68083-500 |
| >Company | >Ingredient | >NDC |
EDARAVONE drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
EDARAVONE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 |
| XGen Pharmaceuticals DJB Inc | edaravone | 39822-4500 |
| Piramal Critical Care Inc | edaravone | 66794-259 |
| Gland Pharma Limited | edaravone | 68083-500 |
| >Company | >Ingredient | >NDC |
EDARAVONE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
EDARAVONE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | edaravone | 0781-3527 |
| XGen Pharmaceuticals DJB Inc | edaravone | 39822-4500 |
| Piramal Critical Care Inc | edaravone | 66794-259 |
| Gland Pharma Limited | edaravone | 68083-500 |
| >Company | >Ingredient | >NDC |
EDARAVONE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
